Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Antiviral Chemistry & Chemotherapy|August 17, 2010
Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitorsGiuseppe La Regina, Antonio Coluccia, Romano Silvestri
Molecules (Basel, Switzerland)|September 13, 2025
Metabolism, a Blossoming Target for Small-Molecule Anticancer DrugsMichela Puxeddu, Romano Silvestri, Giuseppe La Regina
Molecules (Basel, Switzerland)|May 11, 2024
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer TherapyDomiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 29, 2019
Towards modern anticancer agents that interact with tubulinGiuseppe La Regina, Antonio Coluccia, Valentina Naccarato, et al.
ACS Combinatorial Science|January 21, 2011
Open vessel and cooling while heating microwave-assisted synthesis of pyridinyl N-aryl hydrazonesGiuseppe La Regina, Valerio Gatti, Francesco Piscitelli, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Indolyl aryl sulphones as HIV-1 reverse transcriptase inhibitors: docking and 3D QSAR studiesRino Ragno, Antonia Coluccia, Giuseppe La Regina, et al.
Molecules (Basel, Switzerland)|October 16, 2024
Targeting CBP and p300: Emerging Anticancer AgentsDomiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
Molecules (Basel, Switzerland)|November 26, 2022
Emerging Direct Targeting β-Catenin AgentsMarianna Nalli, Domiziana Masci, Andrea Urbani, et al.
ACS Combinatorial Science|March 22, 2012
Venting-while-heating microwave-assisted synthesis of 3-arylthioindolesGiuseppe La Regina, Valerio Gatti, Valeria Famiglini, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Emerging Therapeutic Agents for Colorectal CancerMarianna Nalli, Michela Puxeddu, Giuseppe La Regina, et al.
Pageof 12